NewsBenzinga이뮤니어링, 아테비메티닙의 데이터가 RAS 변이 대장암 및 폐암 모델에서 PD-1 체크포인트 차단제의 활성 개선을 보여준다고 발표···대장암 모델에서 50%의 지속적 완전 퇴행 효과 입증 이뮤니어링, 아테비메티닙의 데이터가 RAS 변이 대장암 및 폐암 모델에서 PD-1 체크포인트 차단제의 활성 개선을 보여준다고 발표···대장암 모델에서 50%의 지속적 완전 퇴행 효과 입증 Benzinga 2026.11.06 14:02 (GMT+0) Open on Benzinga Other news Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart Canton Strategic Holdings Q3 Revenue of $3.05M, Net Loss Widens to $35.1M StablecoinX Q3 Revenue Reaches $478,000, Net Loss $100 Million Nvidia Employee Letter to Board Warns Company Faces Talent Loss If Huang Isn't Reinstated as CEO
Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market
Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin
Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart